Skip to main content
  • Advertise
    Want to Advertise with Us?
    Conquer welcomes advertising and sponsorship collaborations with reputable companies offering high-quality products and services to people affected by cancer.
  • Affiliated Brands
    Academy of Oncology Nurse & Patient Navigators
    The Academy of Oncology Nurse & Patient Navigators (AONN+) is the largest national specialty organization dedicated to improving patient care and quality of life by defining, enhancing, and promoting the role of oncology nurse and patient navigators. Our organization of over 8,900 members was founded in May 2009 to provide a network for all professionals involved and interested in patient navigation and survivorship care services to better manage the complexities of the cancer care treatment continuum for their patients. We view our organization as one consisting of “professional patient advocates” and, to that end, we support and serve our members.
    Journal of Oncology Navigation & Survivorship
    The Journal of Oncology Navigation & Survivorship (JONS) promotes reliance on evidence-based practices in navigating patients with cancer and their caregivers through diagnosis, treatment, and survivorship. JONS also seeks to strengthen the role of nurse and patient navigators in cancer care by serving as a platform for these professionals to disseminate original research findings, exchange best practices, and find support for their growing community.
    The Oncology Nurse-APN/PA
    The Oncology Nurse-APN/PA (TON) provides coverage of the wide spectrum of oncology-related events, trends, news, therapeutics, diagnostics, organizations, and legislation that directly affect hematology/oncology nurses and advanced practitioners involved in healthcare delivery and product utilization. The scope and coverage include a unique presentation of news and events that are shaping the care of patients with cancer.
  • Healthcare Providers
  • Contribute

August 2021 Vol 7 No 4

Nutrition Tips for Young Patients Facing Cancer
Maintaining good nutrition is especially important for children and young people who are still growing and developing. These recommendations will help them stay healthy and maintain good appetite while fighting cancer. Read More ›

Biomarker Testing Is Driving the Development of New Therapies
Non-Hodgkin lymphoma survivor Dan Dean spoke with several experts about the advances in genomic testing, which have enabled oncologists to treat patients with new “targeted therapies” that fight cancer based on the specific features of a tumor. Read More ›

Being a Bedside Advocate, Part 2: What the “White Coats” Want You to Know
Kimberley Norris uses her experience as her husband’s bedside advocate to describe what it means to be a bedside advocate, providing physicians’ practical tips for people who are in a similar situation. Read More ›

Three Words Is All It Took for My Life to Change Drastically: The Chick Mission
Amanda Rice was 37 when she was diagnosed with breast cancer for the first time. She describes her decision to freeze her eggs after her diagnosis, which led her to launch the nonprofit organization The Chick Mission to educate women on the impact of cancer treatment on becoming mothers. Read More ›

Saying I Love You, and Having No Regrets
As a palliative care nurse, Amy Velasquez knows what it means to take care of patients and their families dealing with real pain and suffering. Here, Amy unravels her experience caring for her mom, who tested positive for COVID-19 in October 2020. Read More ›

Truseltiq Second Targeted Therapy Approved by the FDA for Patients with Advanced or Metastatic Cholangiocarcinoma and the FGFR2 Biomarker
In late May 2021, the FDA approved Truseltiq (infigratinib), a new targeted therapy, for adults with previously treated, unresectable, locally advanced or metastatic cholangiocarcinoma and FGFR2 fusion or other rearrangement, as detected by an FDA-approved test. Read More ›

The Human Element Amid COVID-19 and Cancer
Sheryl Gundersen, who worked as a software sales professional for 35 years, became an expert in interpreting her customers’ body language. In this article, she describes how she used these skills in her personal journey with breast cancer while facing people wearing masks during the COVID-19 pandemic. Read More ›

Darzalex Faspro Receives New FDA Indication, in Combination with Pomalyst and Dexamethasone, for the Treatment of Patients with Multiple Myeloma
In July 2021, the FDA approved a new indication for Darzalex Faspro (daratumumab and hyaluronidase-fihj), for use in combination with Pomalyst (pomalidomide) and dexamethasone, for adults with multiple myeloma who have received at least 1 previous line of therapy. Read More ›

No One Told Me
Nobody told Donna Avery that esophageal cancer is often fatal when diagnosed at a late stage. Now 7 years after her diagnosis, she chronicles her experience with radiation and dealing with this rare cancer, which accounts for only 1% of all new cancer diagnoses in the United States. Read More ›

Cancer Treatment Made More Difficult by the Pandemic
The COVID-19 pandemic has been a source of constant stress for many people, especially for patients with cancer, who have had to deal with the added burdens, delays, and disruptions caused by this worldwide phenomenon affecting all facets of our lives. Read More ›

Page 1 of 2